Back pain is debilitating and limiting. It forces changes to the way people live and affects their quality of lie. Gelmetix addresses the most common cause of this critical problem through an efficient, cost effective and drug-free approach to preventing pain and restoring functionality and movement.
Our patented polymer gel helps to restore the natural integrity of the disc itself. Injected directly, it rehydrates and stabilises, bringing back load-bearing properties and restoring the movement of the patient. Our polymer gel technology also has the potential to be adapted and extended for other uses.
Gelmetix was founded in 2012, as a spin-off from the University of Manchester. In December 2020, Gelmetix was named “one of the most promising biotech start-ups in Europe” by EIT Health Catapult.
Company Details
- Employees
- 8
- Founded
- 2012
- Address
- 25 Eccleston Place, London,england Sw1w 9nf,united Kingdom
- Industry
- Medical Device
- Website
- http://www.gelmetix.com
- Keywords
- Spine, Back pain, Biotech, Medtech.
- HQ
- London, England
Gelmetix Questions
Gelmetix's website is http://www.gelmetix.com
Gelmetix's LinkedIn profile is https://uk.linkedin.com/company/gelmetix
Gelmetix has
8 employees.
View email and phone details for 8
employees at Gelmetix.
Gelmetix's industry is
Medical Device
Gelmetix's top competitors are
Celex Oncology Innovations Ltd,
30 Technology,
Avitus Orthopaedics,
Virtamed,
Becapio,
Jellagen,
Hyalex Orthopaedics Inc.,
Field Orthopaedics Usa,
Miach Orthopaedics, Inc.,
Solascure.
Gelmetix's categories are Medical Device
Gelmetix's founding year is 2012
